Target intelligence / Profile preview

Mediator of RNA polymerase II transcription subunit 15 KIX domain (MED15 KIX)

Target
MED15 KIX
Molecular classification
Transcription factor coactivator, Mediator complex subunit, Protein interaction domain
01

Overview

The Mediator of RNA polymerase II transcription subunit 15 (MED15) KIX domain is a specialized protein-protein interaction module located within the Mediator complex, a massive multi-protein assembly that bridges DNA-bound transcription factors to the RNA polymerase II machinery (UniProt Q96RN5). The KIX domain specifically functions as a docking site for the transactivation domains of various transcription factors, most notably the Sterol Regulatory Element-Binding Proteins (SREBPs), which are master regulators of lipid and cholesterol metabolism (PubMed: 25154354). Beyond metabolism, the MED15 KIX domain is implicated in several signaling pathways, including TGF-beta and p53-mediated stress responses. In clinical oncology, MED15 is frequently overexpressed and is associated with tumor recurrence, metastasis, and resistance to therapies in prostate and breast cancers (PubMed: 24631377). Consequently, the KIX domain has emerged as a high-priority therapeutic target for the development of small-molecule inhibitors designed to disrupt pathological protein-protein interactions (PubMed: 28846511). Current research focuses on identifying selective ligands that can block these interactions to treat metabolic diseases and advanced malignancies without affecting the structurally similar KIX domains of other essential coactivators like CBP or p300 (PubMed: 31216345).

Other names
Mediator complex subunit 15Activator-recruited cofactor 105 kDa componentARC105PC2 glutamine/rich-associated proteinPCQAPTIG-1CTG7ATGR1
02

Mechanism of action

Inhibition of protein-protein interactions (PPI) between the KIX domain and transactivation domains of transcription factors such as SREBP, p53, or GATA.

03

Biological functions

Transcription regulationRNA polymerase II recruitmentLipid metabolismCellular stress responseTGF-beta signaling
04

Disease associations

Prostate cancerBreast cancerHead and neck squamous cell carcinomaMetabolic disorderObesityDyslipidemia
05

Safety considerations

Off-target effects on other KIX-containing proteins such as CBP and p300Potential for broad transcriptional dysregulationDisruption of essential metabolic homeostasis
06

Interacting drugs

Myricetin

2 more in the full profile.

07

Biomarkers

MED15 mRNA expressionMED15 protein nuclear localizationSREBP-1 activity levels

Beyond the preview

Go deeper on Mediator of RNA polymerase II transcription subunit 15 KIX domain (MED15 KIX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediator of RNA polymerase II transcription subunit 15 KIX domain (MED15 KIX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call